DX & VX CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,830 KRW | +4.43% |
|
-0.70% | -52.12% |
| 06-10 | Malaysian Genomics Resource Forge Strategic Alliance with South Korean Healthcare Solutions Provider | MT |
| 2023 | Dx&Vx Co-Develops Bio-Healthcare Big Data Platform with LG CNS | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 61.8M | - | - | - | - | - | |
| 3.7B | - | |||||
| 2.28B | - | |||||
| 1.99B | - | - | - | - | - | |
| 1.6B | - | |||||
| 999M | - |
